Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term
A 16-Week Growth Study of an Extensively Hydrolyzed Infant Formula, 3 Months Treatment and 1 Month Follow-up for a Duration of 4 Months.
1 other identifier
interventional
35
1 country
1
Brief Summary
The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 8, 2009
CompletedFirst Posted
Study publicly available on registry
July 10, 2009
CompletedJuly 10, 2009
July 1, 2009
1.4 years
July 8, 2009
July 9, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
An extensively hydrolyzed formula is nutritionally adequate for normal growth of healthy full-term infants
16 weeks
Study Arms (1)
Extensively hydrolyzed infant formula
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- At birth:
- Healthy, term (37-42 weeks) infant
- Weight for length between the 10th and 90th percentile according to the National Center for Health Statistics (NCHS) growth charts
- At time of enrollment:
- \< or = 21 days post-natal age
- Weight for length between the 10th and 90th percentile according to the National Center for Health Statistics (NCHS) growth charts
- Exclusively formula fed
- Written informed consent of parent/guardian
You may not qualify if:
- At the time of enrollment: partially human-milk fed; fed baby/solid foods
- Conditions requiring feedings other than those specified in the protocol
- Documented or suspected cow's milk allergy and/or soy protein allergies
- Major congenital deformities
- Suspected or documented systemic or congenital infections
- Evidence of cardiac, respiratory, hematological, gastrointestinal, or other systemic diseases
- Participation in any other clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Virginia
Charlottesville, Virginia, 22908, United States
Study Officials
- STUDY DIRECTOR
Cynthia M Barber, PhD
Perrigo Nutritionals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
July 8, 2009
First Posted
July 10, 2009
Study Start
July 1, 2007
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
July 10, 2009
Record last verified: 2009-07